Amdocs Reports Q2 2024 Financial Results

Ticker: DOX · Form: 6-K · Filed: May 9, 2024 · CIK: 1062579

Amdocs LTD 6-K Filing Summary
FieldDetail
CompanyAmdocs LTD (DOX)
Form Type6-K
Filed DateMay 9, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: earnings, financial-results, sec-filing

Related Tickers: DOX

TL;DR

Amdocs dropped its Q2 2024 earnings report on 5/8, check the exhibits for deets.

AI Summary

On May 8, 2024, Amdocs Limited announced its financial results for the quarter ended March 31, 2024. The company issued a press release and accompanying presentation detailing these results, which are furnished as exhibits to this Form 6-K filing.

Why It Matters

This filing provides investors with the latest financial performance data for Amdocs, crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial results disclosure, not indicating any new or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report Amdocs Limited's financial results for the quarter ended March 31, 2024, via a press release and accompanying presentation.

When did Amdocs announce its financial results?

Amdocs announced its financial results on May 8, 2024.

What period do the financial results cover?

The financial results cover the quarter ended March 31, 2024.

What exhibits are furnished with this Form 6-K?

Exhibits 99.1 (press release) and 99.2 (presentation) are furnished with this Form 6-K.

Is the information in this Form 6-K considered 'filed' with the SEC?

No, the information in this Form 6-K, including the exhibits, is not deemed 'filed' for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section.

Filing Stats: 277 words · 1 min read · ~1 pages · Grade level 9.2 · Accepted 2024-05-08 21:38:31

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMDOCS LIMITED By: /s/ Matthew E. Smith Matthew E. Smith Secretary and Authorized Signatory Date: May 8, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing